- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Fr | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 14.05. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 26.04. | Jin Medical International Ltd. - 20-F, Annual and transition report of foreign private issuers | 1 | SEC Filings | ||
| 12.04. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 29.03. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 01.03. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 2 | SEC Filings | ||
| 27.02. | How Is The Market Feeling About Jin Medical International? | 1 | Benzinga.com | ||
| 23.02. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 1 | SEC Filings | ||
| 08.02. | Why Is Jin Medical International (ZJYL) Stock Moving Today? | 5 | InvestorPlace | ||
| 01.02. | Jin Medical International Ltd. - 6-K, Report of foreign issuer | 5 | SEC Filings | ||
| 19.12.23 | Pre-market Movers: Infobird, Jin Medical International, Motus GI, Panbela Therapeutics, Shengfeng Development | 943 | AFX News | BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.10 A.M. ET).In the Green Infobird Co., Ltd (IFBD) is up over 80% at $2.44.
Jin... ► Artikel lesen | |
| 14.12.23 | Jin Medical International Ltd. Enters into Memorandum of Understanding to Acquire Medical Equipment Sharing Platform | 319 | GlobeNewswire (Europe) | Changzhou City, China, Dec. 14, 2023 (GLOBE NEWSWIRE) -- JIN MEDICAL INTERNATIONAL LTD. (the "Company" or "JinMed") (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that... ► Artikel lesen | |
| 23.08.23 | Jin Medical International Ltd. Announces Financial Results for Six Months Ended March 31, 2023 | 343 | PR Newswire | CHANGZHOU, China, Aug. 23, 2023 /PRNewswire/ -- Jin Medical International Limited ("the Company" or "JinMed") (NASDAQ: ZJYL), a Cayman Islands holding company with Chinese operating entities that... ► Artikel lesen |
13 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| PLUS THERAPEUTICS | 1,690 | -2,76 % | Plus Therapeutics Inc.: Plus Therapeutics Showcases Leptomeningeal Metastases Programs at 2024 SNO/ASCO Conference | ||
| ATOSSA THERAPEUTICS | 1,266 | -6,22 % | Atossa Therapeutics, Inc.: Atossa Therapeutics Completes Enrollment of 80mg Pharmacokinetic Run-In Cohort in Phase 2 EVANGELINE Clinical Trial Evaluating (Z)-Endoxifen as a Neoadjuvant Treatment for ER+ / HER2- Breast Cancer | SEATTLE, July 22, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) ("Atossa" or the "Company") today announced that the 12-patient 80mg pharmacokinetic (PK) run-in cohort of the Phase... ► Artikel lesen | |
| CO-DIAGNOSTICS | 1,060 | +2,91 % | Co-Diagnostics, Inc. Reports First Quarter 2024 Financial Results | SALT LAKE CITY, May 9, 2024 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX) ("Co-Dx," or the "Company"), a molecular diagnostics company with a unique, patented platform for the development... ► Artikel lesen | |
| EMEIS | 13,230 | +1,21 % | emeis: Growth in Revenue in First-Half 2024 at €2,772 Million (Up 9.2%) | Regulatory News:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240726471228/en/
emeis (Paris:EMEIS):
Growth in revenue in first-half... ► Artikel lesen | |
| ASENSUS SURGICAL | 0,299 | -3,92 % | Asensus Surgical, Inc.: Asensus Surgical Receives FDA 510(k) Clearance for Senhance Surgical System in Urology | RESEARCH TRIANGLE PARK, N.C., July 23, 2024 (GLOBE NEWSWIRE) -- Asensus Surgical, Inc. (NYSE American: ASXC), a global leader of innovative digital solutions for the operating room, today announced... ► Artikel lesen | |
| INVIVO THERAPEUTICS HOLDINGS | 0,200 | 0,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 23.02.2024 | The following instruments on Boerse Frankfurt do have their last trading day on 23.02.2024.Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 23.02.2024.ISIN NameCA58503M4083 MEDIVOLVE... ► Artikel lesen | |
| AMBU | 18,310 | +0,03 % | Ambu A/S: Reporting of transactions made by persons discharging managerial responsibilities | Pursuant to the Market Abuse Regulation, article 19, Ambu A/S hereby notifies receipt of information of the following transaction(s) made by persons discharging managerial responsibilities in Ambu A/S... ► Artikel lesen | |
| NANO-X IMAGING | 8,590 | +9,29 % | Nano-X Imaging Ltd. - 6-K, Report of foreign issuer | ||
| EKSO BIONICS | 1,200 | +5,26 % | Ekso Bionics Holdings, Inc.: Ekso Bionics to Report Second Quarter 2024 Financial Results on July 29, 2024 | ||
| NOVACYT | 0,636 | +7,43 % | Novacyt says revenue to more than triple following strong first half | ||
| BUTTERFLY NETWORK | 1,065 | -2,29 % | Butterfly Network Reports First Quarter 2024 Financial Results | BURLINGTON, Mass. & NEW YORK--(BUSINESS WIRE)--Butterfly Network, Inc. (NYSE: BFLY) ("Butterfly" or the "Company"), a digital health company transforming care with handheld, whole-body ultrasound... ► Artikel lesen | |
| AETHLON MEDICAL | 0,354 | +5,36 % | Aethlon Medical, Inc.: Aethlon Medical Announces Financial Results for the Fiscal Year Ended March 31, 2024 and Provides Corporate Update | Conference Call to be Held Today at 4:30 p.m. ET
SAN DIEGO, June 27, 2024 /PRNewswire/ -- Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to... ► Artikel lesen | |
| GOODRX | 8,850 | +1,26 % | Boehringer Ingelheim and GoodRx announce exclusive patient affordability initiative for Adalimumab-adbm injection, Boehringer's biosimilar to Humira | First biosimilar with an exclusive low cash price on the GoodRx platform RIDGEFIELD, Conn. and SANTA MONICA, Calif., July 18, 2024 /PRNewswire/ -- Boehringer Ingelheim and GoodRx (Nasdaq: GDRX),... ► Artikel lesen | |
| CARMAT | 2,600 | +0,58 % | CARMAT accelerates its sales momentum and reiterates its confidence in its development outlook | 20 implants of the Aeson artificial heart performed in the first half of 2024
Pace of 4 implants per month in the second quarter
Half-year sales at €3.2 million, higher than the... ► Artikel lesen | |
| JOINT CORP | 14,220 | +4,33 % | The Joint Corp. to Host Conference Call on Thursday, August 8th to Discuss Second Quarter 2024 Results |
JIN MEDICAL INTERNATIONAL LTD gehört der Branche Gesundheitswesen an. Mit einer aktuellen Kursveränderung von +0,060 (+1,90 %) liegt der Kurs bei 3,210 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu JIN MEDICAL INTERNATIONAL LTD finden Sie auf Wallstreet Online.
